DexCom Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . DexCom Inc
DXCM Stock  USD 66.37  0.69  1.03%   
DexCom's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing DexCom's valuation are provided below:
Gross Profit
2.7 B
Profit Margin
0.1596
Market Capitalization
26.3 B
Enterprise Value Revenue
5.6618
Revenue
4.5 B
There are over one hundred nineteen available fundamental signals for DexCom Inc, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to verify DexCom's prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 1st of January 2026, Market Cap is likely to grow to about 267.1 M. Also, Enterprise Value is likely to grow to about 231.9 M

DexCom Total Revenue

4.23 Billion

Check DexCom financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DexCom's main balance sheet or income statement drivers, such as Interest Expense of 12.2 M, Other Operating Expenses of 3.6 B or Operating Income of 630 M, as well as many indicators such as Price To Sales Ratio of 7.41, Dividend Yield of 0.0 or PTB Ratio of 10.1. DexCom financial statements analysis is a perfect complement when working with DexCom Valuation or Volatility modules.
  
Build AI portfolio with DexCom Stock
Check out the analysis of DexCom Correlation against competitors.

DexCom Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets6.8 B6.5 B2.5 B
Slightly volatile
Cash636.4 M606.1 M416.6 M
Slightly volatile
Cash And Short Term Investments2.7 B2.6 B1.2 B
Slightly volatile
Common Stock Shares Outstanding254.7 M412.7 M324.3 M
Slightly volatile
Liabilities And Stockholders Equity6.8 B6.5 B2.5 B
Slightly volatile
Total Current Assets4.5 B4.3 B1.8 B
Slightly volatile
Other Current Liabilities1.4 B1.3 B379.5 M
Slightly volatile
Total Current Liabilities3.1 B2.9 B733.7 M
Slightly volatile
Property Plant And Equipment Net1.5 B1.4 B479.1 M
Slightly volatile
Accounts Payable362.6 M345.3 M126.3 M
Slightly volatile
Non Current Assets Total2.3 B2.2 B703.1 M
Slightly volatile
Non Currrent Assets Other56.4 M53.7 M15.4 M
Slightly volatile
Other Assets445.9 M424.7 M131.7 M
Slightly volatile
Common Stock Total Equity483 K460 K175.8 K
Slightly volatile
Non Current Liabilities Total1.5 B1.4 B854.7 M
Slightly volatile
Total Liabilities4.6 B4.4 B1.6 B
Slightly volatile
Property Plant And Equipment Gross2.2 B2.1 B592.4 M
Slightly volatile
Common Stock483 K460 K194.6 K
Slightly volatile
Property Plant Equipment1.4 B1.3 B453.4 M
Slightly volatile
Other Liabilities83 M79 M32.6 M
Slightly volatile
Short Term Investments2.1 B2 B827.7 M
Slightly volatile
Short and Long Term Debt Total2.7 B2.6 B1 B
Slightly volatile
Net Receivables1.1 B1 B358 M
Slightly volatile
Inventory569.7 M542.6 M183.1 M
Slightly volatile
Short Term Debt1.3 B1.2 B217 M
Slightly volatile
Current Deferred Revenue4.7 M8 M4.1 M
Slightly volatile
Net Tangible Assets2.6 B2.5 B1 B
Slightly volatile
Capital Surpluse1.5 B2.6 B1.4 B
Slightly volatile
Non Current Liabilities Other17.2 M18.1 M43.4 M
Slightly volatile
Long Term Debt Total852.9 M1.4 B651.6 M
Slightly volatile
Short and Long Term Debt1.5 B1.4 B516.3 M
Slightly volatile
Long Term Investments125.3 M119.3 M27.1 M
Slightly volatile
Capital Lease Obligations121.9 M146 M65.9 M
Slightly volatile
Net Invested Capital3.4 B4.5 B2.1 B
Slightly volatile
Net Working Capital2.1 B1.4 B1.4 B
Slightly volatile
Capital Stock251.4 K460 K169.5 K
Slightly volatile

DexCom Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses3.6 B3.4 B1.3 B
Slightly volatile
Research Development580 M552.4 M277.7 M
Slightly volatile
Total Operating Expenses1.9 B1.8 B800.8 M
Slightly volatile
Depreciation And Amortization228.6 M217.7 M68.9 M
Slightly volatile
Selling General Administrative1.1 B1.1 B460.3 M
Slightly volatile
Selling And Marketing Expenses203.9 M194.2 M64.1 M
Slightly volatile
Total Revenue4.2 B4 B1.5 B
Slightly volatile
Cost Of Revenue1.7 B1.6 B546.8 M
Slightly volatile
Interest Income140.9 M134.2 M30.1 M
Slightly volatile
Reconciled Depreciation113.1 M217.7 M65.5 M
Slightly volatile

DexCom Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow595.9 M567.5 M377.3 M
Slightly volatile
Depreciation228.6 M217.7 M68.9 M
Slightly volatile
Capital Expenditures376.7 M358.8 M148.1 M
Slightly volatile
End Period Cash Flow308.4 M607.3 M396.8 M
Slightly volatile
Change To Liabilities366.6 M349.1 M120.7 M
Slightly volatile
Stock Based Compensation161.9 M170.4 M194.9 M
Slightly volatile
Issuance Of Capital Stock21.3 M28.2 M15.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.417.802619.4757
Slightly volatile
Days Sales Outstanding51.3293.544369.9173
Slightly volatile
Book Value Per Share5.465.19642.6365
Slightly volatile
Average Payables1.3 M1.4 M1.3 M
Slightly volatile
Stock Based Compensation To Revenue0.04010.0423169
Slightly volatile
Capex To Depreciation1.821.64812.4089
Pretty Stable
EV To Sales7.888.293819.1862
Slightly volatile
Inventory Turnover5.732.93924.6003
Slightly volatile
Days Of Inventory On Hand68.3712491.6378
Slightly volatile
Payables Turnover4.394.61867.5824
Slightly volatile
Sales General And Administrative To Revenue0.260.27070.9667
Slightly volatile
Research And Ddevelopement To Revenue0.130.1370.7978
Slightly volatile
Capex To Revenue0.08450.0890.1839
Slightly volatile
Cash Per Share6.696.37483.3804
Slightly volatile
Days Payables Outstanding42.5879.028457.8371
Slightly volatile
Intangibles To Total Assets0.02880.01950.0318
Slightly volatile
Net Debt To EBITDA1.382.09512.3942
Very volatile
Current Ratio1.391.46715.0668
Slightly volatile
Tangible Book Value Per Share5.134.88452.506
Slightly volatile
Receivables Turnover7.793.90196.0083
Slightly volatile
Graham Number8.0412.90346.4568
Slightly volatile
Debt To Equity1.291.23060.6796
Slightly volatile
Capex Per Share0.930.88670.39
Slightly volatile
Revenue Per Share10.479.96733.9283
Slightly volatile
Interest Debt Per Share6.766.44152.7303
Slightly volatile
Debt To Assets0.40.3990.2591
Slightly volatile
Operating Cycle120218162
Slightly volatile
Days Of Payables Outstanding42.5879.028457.8371
Slightly volatile
Ebt Per Ebit1.121.181760.4606
Slightly volatile
Long Term Debt To Capitalization0.660.37040.4106
Slightly volatile
Total Debt To Capitalization0.540.55170.3212
Slightly volatile
Debt Equity Ratio1.291.23060.6796
Slightly volatile
Quick Ratio1.221.2824.7347
Slightly volatile
Net Income Per E B T0.770.81270.9525
Pretty Stable
Cash Ratio0.20.20672.4811
Slightly volatile
Cash Conversion Cycle77.11139104
Slightly volatile
Days Of Inventory Outstanding68.3712491.6378
Slightly volatile
Days Of Sales Outstanding51.3293.544369.9173
Slightly volatile
Fixed Asset Turnover3.352.87524.4646
Slightly volatile
Debt Ratio0.40.3990.2591
Slightly volatile
Price Sales Ratio7.417.802619.4757
Slightly volatile
Asset Turnover0.560.62190.7696
Slightly volatile

DexCom Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap267.1 M254.4 M263.5 M
Slightly volatile
Enterprise Value231.9 M220.9 M228.1 M
Slightly volatile

DexCom Fundamental Market Drivers

Forward Price Earnings26.8817
Cash And Short Term Investments2.6 B

DexCom Upcoming Events

8th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About DexCom Financial Statements

DexCom investors utilize fundamental indicators, such as revenue or net income, to predict how DexCom Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue8 M4.7 M
Total Revenue4 B4.2 B
Cost Of Revenue1.6 B1.7 B
Stock Based Compensation To Revenue 0.04  0.04 
Sales General And Administrative To Revenue 0.27  0.26 
Research And Ddevelopement To Revenue 0.14  0.13 
Capex To Revenue 0.09  0.08 
Revenue Per Share 9.97  10.47 
Ebit Per Revenue 0.15  0.16 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:
How To Invest In DexCom
Details
Is DexCom Stock a good investment?
Details
What is DexCom's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of DexCom Correlation against competitors.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.099
Earnings Share
1.8
Revenue Per Share
11.544
Quarterly Revenue Growth
0.216
Return On Assets
0.0702
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY